Clinical Trial Update: Efficacy and Steroid Sparing Potential Study of DGLA Cream in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and steroid-sparing potential of DGLA cream in moderate-to-severe atopic dermatitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• DGLA Cream (dihomo-γ-linolenic acid cream)

Snippet

Sponsor: DS Biopharma | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED